EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Cytometry Part B: Clinical Cytometry

ISSN 1552-4949 · Wiley

Latest articles

  1. Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B ‐cell acute lymphoblastic leukemia: A report from The Cytometry Society, India

    Prashant Tembhare, Kunal Sehgal, Karthik Bommannan, Khaliqur Rahman, Sachin Jain, Nitin Dayal, Sitaram Ghogale, Ananthvikas Jayaram, Man Updesh Singh Sachdeva, Ritu Gupta, Papagudi G. Subramanian, Prabhu Manivannan, Mohan Galande, Manasi Mundada, Asish Rath, Phaneendra Datari, Sweta Rajpal, Gaurav Chatterjee, Nilesh Deshpande, Kotteeswari Kathirvel, Kuldeep Singh, Bhausaheb Bagal, Sachin Punatar, Ambreen Pandrowala, Chetan Dhamne, Anil Handoo, Julio‐Javier, Alexander Popov, Dalia Salem, David Westerman, Alberto Orfao

    Published: 2026-08-04DOI: 10.1002/cyto.b.70055

  2. Detailed analysis of TRBC1 distribution in T‐cell subsets and its application in T‐cell clonality assessment

    Anumeha Chaturvedi, Simpy Raj, Jagruti Patil, Twinkle Khanka, Aswathy Anilkumar, Sitaram G. Ghogale, Nilesh Deshpande, Karishma Girase, Suresh Poojari, K. Balaji, Manju Sengar, Bhausaheb Bagal, Hasmukh Jain, Sachin Punatar, Anant Gokarn, Navin Khattry, Dhanalaxmi Shetty, Sweta Rajpal, Pratyusha Gudapati, Nikhil Patkar, Gaurav Chatterjee, Sridhar Epari, Tanuja Shet, Papagudi G. Subramanian, Sumeet Gujral, Prashant R. Tembhare

    Published: 2026-07-30DOI: 10.1002/cyto.b.70054

Volumes

2026 · 992025 · 732024 · 572023 · 552022 · 692021 · 882020 · 602019 · 712018 · 1292017 · 732016 · 1132015 · 592014 · 1032013 · 1072012 · 622011 · 622010 · 662009 · 512008 · 672007 · 692006 · 592005 · 422004 · 472003 · 55

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.